Technical Analysis for EYES - Second Sight Medical Products, Inc.

Grade Last Price % Change Price Change
grade F 0.82 -7.87% -0.07
EYES closed down 7.87 percent on Wednesday, January 16, 2019, on 32 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical EYES trend table...

Date Alert Name Type % Chg
Jan 16 Wide Bands Range Expansion 0.00%
Jan 16 Down 3 Days in a Row Weakness 0.00%
Jan 15 20 DMA Resistance Bearish -7.87%
Jan 15 Wide Bands Range Expansion -7.87%
Jan 14 Fell Below 20 DMA Bearish -8.89%
Jan 14 Stochastic Sell Signal Bearish -8.89%
Jan 14 Wide Bands Range Expansion -8.89%
Jan 14 Overbought Stochastic Strength -8.89%
Jan 11 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -15.46%
Jan 11 Narrow Range Bar Range Contraction -15.46%

Older signals for EYES ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Second Sight Medical Products, Inc. was founded in 1998 with a mission to restore vision to the blind. Today, Second Sight’s Argus II retinal prosthesis provides functional vision to patients blinded by outer retinal degenerations such as retinitis pigmentosa. The company’s innovative technology is the only retinal prosthesis approved by the United States FDA and the first device to receive a CE mark in Europe. The company’s transformative prosthetic device allows blind individuals to gain greater independence in their daily lives. Second Sight believes that its award winning technology will serve as a platform to treat nearly all forms of blindness and could be extended to other neurostimulation applications beyond vision restoration. The Argus II system is currently available in the US and Europe and the company is actively pursuing additional geographic markets. With next generation products under development, the company plans to continue developing, manufacturing and marketing its innovative visual prostethics around the world. Second Sight’s US Headquarters are in Sylmar, California. European Headquarters are in Lausanne, Switzerland.
Is EYES a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.58
52 Week Low 0.635
Average Volume 596,915
200-Day Moving Average 1.5705
50-Day Moving Average 1.0921
20-Day Moving Average 0.8973
10-Day Moving Average 0.9425
Average True Range 0.0892
ADX 29.51
+DI 12.1893
-DI 24.5304
Chandelier Exit (Long, 3 ATRs ) 0.7524
Chandelier Exit (Short, 3 ATRs ) 0.9026
Upper Bollinger Band 1.0594
Lower Bollinger Band 0.7352
Percent B (%b) 0.26
BandWidth 36.130614
MACD Line -0.0415
MACD Signal Line -0.0491
MACD Histogram 0.0076
Fundamentals Value
Market Cap 46.57 Million
Num Shares 56.8 Million
EPS -0.71
Price-to-Earnings (P/E) Ratio -1.15
Price-to-Sales 12.04
Price-to-Book 3.29
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.93
Resistance 3 (R3) 0.94 0.91 0.91
Resistance 2 (R2) 0.91 0.89 0.91 0.90
Resistance 1 (R1) 0.87 0.87 0.86 0.86 0.90
Pivot Point 0.84 0.84 0.84 0.84 0.84
Support 1 (S1) 0.80 0.82 0.79 0.79 0.74
Support 2 (S2) 0.77 0.80 0.77 0.74
Support 3 (S3) 0.73 0.77 0.73
Support 4 (S4) 0.72